SUBSCRIBE
SUBSCRIBE
News   Business

Illumina, Inc. Announces Scale-Up of Genome Analyzers at The Broad Institute

November 5, 2009 | 
1 min read

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.

Alliances
Illumina, Inc.
MORE ON THIS TOPIC
Podcast
RFK Jr. Advances, Q4 Earnings Roll Out and a Non-Opioid Pain Drug Hits the Market
February 5, 2025
 · 
1 min read
 · 
Heather McKenzie
Illustration of two hands shaking while another hand gently grips a wrist
Collaboration
The Top 7 Biopharma Licensing Deals of 2024
February 5, 2025
 · 
8 min read
 · 
Tristan Manalac
Illustration of a computer choosing from a display
Opinion
Pharma M&A Uptick Ushers in a New Era of Data Integration
February 5, 2025
 · 
4 min read
 · 
Raj Indupuri
Brussels, Belgium. 21st December 2020. Exterior view of Pfizer Pharmaceutical company's offices.
Earnings
Pfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing
February 4, 2025
 · 
4 min read
 · 
Annalee Armstrong